.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Predict branded drug patent expiration
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Deloitte
Johnson and Johnson
McKesson
Cipla
Mallinckrodt
Teva
Accenture
Julphar
Express Scripts
Moodys

Generated: June 28, 2017

DrugPatentWatch Database Preview

COUMADIN Drug Profile

« Back to Dashboard

Which patents cover Coumadin, and when can generic versions of Coumadin launch?

Coumadin is a drug marketed by Bristol Myers Squibb and is included in one NDA.

The generic ingredient in COUMADIN is warfarin sodium. There are twenty-one drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the warfarin sodium profile page.

Summary for Tradename: COUMADIN

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list6
Bulk Api Vendors: see list81
Clinical Trials: see list102
Patent Applications: see list3,987
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:COUMADIN at DailyMed

Pharmacology for Tradename: COUMADIN

Drug ClassVitamin K Antagonist
Mechanism of ActionVitamin K Inhibitors
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bristol Myers Squibb
COUMADIN
warfarin sodium
INJECTABLE;INJECTION009218-024Feb 7, 1995DISCNNoNo► Subscribe► Subscribe
Bristol Myers Squibb
COUMADIN
warfarin sodium
TABLET;ORAL009218-025Nov 18, 1996ABRXYesNo► Subscribe► Subscribe
Bristol Myers Squibb
COUMADIN
warfarin sodium
TABLET;ORAL009218-022Mar 1, 1990ABRXYesNo► Subscribe► Subscribe
Bristol Myers Squibb
COUMADIN
warfarin sodium
TABLET;ORAL009218-005Approved Prior to Jan 1, 1982ABRXYesYes► Subscribe► Subscribe
Bristol Myers Squibb
COUMADIN
warfarin sodium
TABLET;ORAL009218-023Aug 24, 1993ABRXYesNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Medtronic
UBS
Johnson and Johnson
Colorcon
Covington
Farmers Insurance
Federal Trade Commission
Mallinckrodt
Novartis
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot